Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Condrosulf vs Celebrex in Knee Osteoarthritis
NCT02079727Phase 3Completed
- Sponsor
- IBSA Group
- Start
- Jun 2014
- Primary completion
- Oct 2015
- Modality
- Biomacromolecule, Polysaccharide, GAG (Glycosaminoglycan)
- Countries
- 5
01
Overview
A Phase 3 trial of chondroitin sulfate in osteoarthritis (OA), sponsored by IBSA Group. Started Jun 2014; status: completed.
02
Drugs
chondroitin sulfate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02079727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079727.